4//SEC Filing
PROGENICS PHARMACEUTICALS INC 4
Accession 0001447348-13-000035
CIK 0000835887operating
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 3:15 PM ET
Size
5.1 KB
Accession
0001447348-13-000035
Insider Transaction Report
Form 4
Youssoufian Hagop
Executive Vice President R&D
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2013-08-01$5.84/sh+150,000$876,000→ 150,000 totalExercise: $5.84Exp: 2023-08-01→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The stock options become exercisable in four equal installments, commencing one year from the grant date.
Documents
Issuer
PROGENICS PHARMACEUTICALS INC
CIK 0000835887
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000835887
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 3:15 PM ET
- Size
- 5.1 KB